Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€19.30

€19.30

-3.020%
-0.6
-3.020%
-
 
29.05.23 / Frankfurt WKN: A12GT3 / Name: Indivior / Stock / Pharmaceuticals / Micro Cap / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Indivior

sharewise wants to provide you with the best news and tools for Indivior, so we directly link to the best financial data sources.

News

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge: https://cdn.content.foolcdn.com/images/1umn9qeh/production/34d887ed4212e8f7cd62f3cec35549f0cf9a39c0-1401x1251.png?w=1401&h=1251
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge

New York City-based Newtyn Management reported a buy of nearly 1.6 million additional Indivior PLC shares, increasing its position by an estimated $62.8 million in the third quarter, according to a

Here's Why Indivior Stock Soared 15% Today: https://g.foolcdn.com/editorial/images/840491/successful-investor.jpg
Here's Why Indivior Stock Soared 15% Today

Shares in Indivior Plc (NASDAQ: INDV) were up by 15.5% at 1 p.m. ET today after management released an excellent set of third-quarter results, upgraded its full-year guidance, and served notice that

Indivior (INDV) Q2 EPS Jumps 104%
Indivior (INDV) Q2 EPS Jumps 104%

Indivior (NASDAQ:INDV), a global pharmaceutical company known for its treatments for opioid use disorder (OUD), reported results on July 31, 2025. The main news was a sharp outperformance compared